The Covid-19 pandemic has triggered a global vaccine race. As of September 27, 2020, there were more than 200 vaccine candidates in preclinical and clinical development, including 11 in phase 3 trials. Wealthy governments that have invested in vaccine candidates have made bilateral agreements with…